USPTO Terminates Rarely Used COVID Patent Fast-Track
Published Date: 4/16/2026
Notice
Summary
The USPTO is ending its Fast-Track program for COVID-19-related patent appeals as of April 16, 2026. This program, which sped up reviews for COVID-19 inventions without fees, wasn’t used much—only one petition was granted. Now, the USPTO will focus on speeding up all patent appeals instead, with no extra costs or changes for most inventors.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 1 costs, 1 mixed.
Paid Fast-Track Alternative Remains (6-Month Target)
Patent applicants can instead seek fast-track status under the Fast-Track Appeals Pilot Program by filing a petition accompanied by a petition fee. That program sets a target of reaching a decision on the ex parte appeal within six months from the date the appeal is entered into the program.
Free COVID Fast-Track for Appeals Ends
The USPTO is terminating the Fast-Track for COVID-19-Related Appeals Pilot Program. Petitions filed after midnight ET on April 16, 2026 will not be granted, so you cannot obtain that COVID-specific free expedited review after that date.
Previously-Granted Fast-Track Status Preserved
If your ex parte appeal received fast-track status through a grantable petition filed by midnight ET on April 16, 2026, it will keep that fast-track status even if the appeal is still pending. Such appeals will retain fast-track status until PTAB jurisdiction ends under 37 CFR 41.35(b).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-08798 — Extension and Modification of the Fast-Track Appeals Pilot Program
The USPTO is extending its Fast-Track Appeals Pilot Program until May 6, 2028, letting inventors speed up their patent appeal reviews. Now, decisions will come even faster—within four months instead of six! This helps inventors get answers quicker without changing fees, making the patent process smoother and snappier.
2026-08101 — Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; DOCX Submission Requirements
The USPTO is asking for public comments on updating their rules about submitting patent applications in DOCX format. If your patent application isn’t in DOCX, you might have to pay a fee starting from January 2024. Comments are open until June 26, 2026, so now’s the time to speak up if you’re affected!
2026-07831 — Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Secrecy and License To Export
The USPTO is asking for your thoughts on renewing a form that helps keep some patent info secret for national security and controls exporting licenses. This affects inventors and businesses dealing with sensitive tech, aiming to keep paperwork light and clear. You’ve got until May 22, 2026, to share your comments—no fees, just your voice!
2026-06903 — PCT Informed Examination Request Pilot Program
Starting April 9, 2026, the USPTO will test a new program where some patent applicants must decide early if they want to move forward, delay, or drop their patent based on international review results. This helps speed up patent processing and cut down on waiting times. If you’re picked, you’ll need to respond quickly or risk losing your application.
2026-06727 — Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Law School Clinic Certification Program
The USPTO is asking for public feedback on renewing a form that helps law school clinics get certified to assist with patent and trademark cases. This update keeps the process smooth and reduces paperwork for students and schools. Comments are open until May 7, 2026, so anyone involved should speak up soon—no extra fees or big changes, just a chance to keep things running well.
2026-05564 — Required Use by Foreign Applicants and Patent Owners of a Patent Practitioner
Starting July 20, 2026, anyone outside the U.S. applying for or owning a U.S. patent must work with a registered patent expert. This change makes the U.S. rules match other countries, helps the Patent Office run smoother, and fights fraud better. If you’re a foreign inventor or patent owner, get ready to team up with a pro to keep your patent game strong!
Previous / Next Documents
Previous: 2026-07441 — 60-Day Notice of Proposed Information Collection: Annual Report-J-NONIMMIGRANT Exchange Visitor Program
The U.S. Department of State wants to update the annual report form for J-1 Exchange Visitor Program sponsors. About 1,425 sponsors will spend around 2 hours each filling out the revised form. They’re asking for public feedback by June 15, 2026, before making the changes official—so now’s the time to speak up!
Next: 2026-07443 — Determination That CHEWTADZY (Tadalafil) Chewable Tablets, 5 Milligrams, 10 Milligrams, 20 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The FDA has decided that CHEWTADZY chewable tablets (5 mg, 10 mg, 20 mg) were not taken off the market because of safety or effectiveness problems. This means generic versions can now get approved if they meet all the rules. Patients and drug makers can expect more affordable options soon, with no safety worries holding things back.